(VIANEWS) – UP Fintech Holding Limited (TIGR), Halozyme Therapeutics (HALO), Pampa Energia S.A. Pampa Energia S.A. (PAM) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. UP Fintech Holding Limited (TIGR)
357.3% sales growth and 5.49% return on equity
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform; and account management services. The company also provides trade execution, margin financing, and securities lending services; asset management and wealth management; ESOP management; fund license application, product design, asset custody, transaction execution, and funding allocation; fund structuring and management; and IPO underwriting services. In addition, it offers market information, community engagement, investor education, and simulated trading services. UP Fintech Holding Limited was founded in 2014 and is based in Beijing, China.
Earnings Per Share
As for profitability, UP Fintech Holding Limited has a trailing twelve months EPS of $0.11.
PE Ratio
UP Fintech Holding Limited has a trailing twelve months price to earnings ratio of 33.18. Meaning, the purchaser of the share is investing $33.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.49%.
Moving Average
UP Fintech Holding Limited’s value is way below its 50-day moving average of $4.07 and under its 200-day moving average of $4.04.
Volume
Today’s last reported volume for UP Fintech Holding Limited is 1024510 which is 31.41% above its average volume of 779591.
Revenue Growth
Year-on-year quarterly revenue growth grew by 32.8%, now sitting on 250.01M for the twelve trailing months.
Yearly Top and Bottom Value
UP Fintech Holding Limited’s stock is valued at $3.65 at 01:22 EST, way below its 52-week high of $5.80 and way higher than its 52-week low of $3.10.
2. Halozyme Therapeutics (HALO)
34.5% sales growth and 153.16% return on equity
Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; XYOSTED, an injection for SC administration of testosterone replacement therapy; NOCDURNA, a sublingual tablet to treat nocturia due to nocturnal polyuria; TLANDO, an oral formulation for testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of multiple blood cancer; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergy and immunology; Sumatriptan injection for migraines; exenatide and teriparatide injections; Makena, a progestin drug to reduce the risk of preterm birth; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $2.58.
PE Ratio
Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 24.15. Meaning, the purchaser of the share is investing $24.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 153.16%.
3. Pampa Energia S.A. Pampa Energia S.A. (PAM)
31.5% sales growth and 30.51% return on equity
Pampa Energía S.A. operates as an independent energy integrated company in Argentina. The company operates through Electricity Generation, Oil and Gas, Petrochemicals, and Holding and Other Business segments. It generates electricity through thermal generation plants, thermal gas-fired thermal generation plants, and hydroelectric power generation systems, as well as through a wind farm. The company also explores for and produces oil and gas; produces petrochemicals, such as styrene, styrene butadiene rubber, and polystyrene; and operates high voltage electricity transmission network. In addition, it engages in gas transportation and advisory services activities. The company was formerly known as Pampa Holding S.A. and changed its name to Pampa Energía S.A. in September 2008. Pampa Energía S.A. was incorporated in 1945 and is based in Buenos Aires, Argentina.
Earnings Per Share
As for profitability, Pampa Energia S.A. Pampa Energia S.A. has a trailing twelve months EPS of $9.34.
PE Ratio
Pampa Energia S.A. Pampa Energia S.A. has a trailing twelve months price to earnings ratio of 6.33. Meaning, the purchaser of the share is investing $6.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.51%.
Yearly Top and Bottom Value
Pampa Energia S.A. Pampa Energia S.A.’s stock is valued at $59.14 at 01:22 EST, below its 52-week high of $59.84 and way above its 52-week low of $32.91.
Revenue Growth
Year-on-year quarterly revenue growth grew by 304.6%, now sitting on 2.17T for the twelve trailing months.
4. Nelnet (NNI)
30.5% sales growth and 4% return on equity
Nelnet, Inc. engages in loan servicing, communications, education technology, services, and payment processing businesses worldwide. Its Loan Servicing and Systems segment provides loan conversion, application processing, borrower updates, customer service, payment processing, due diligence procedures, funds management reconciliation, and claim processing services. This segment also offers student loan servicing software; business process outsourcing services specialized in contact center management, such as inbound calls, outreach campaigns and sales, and interacting with customers through multi-channels. The company's Education Technology, Services, and Payment Processing segment provides financial management services; school information system software; website design and cost effective admissions software; FACTS Giving, a donation platform; and customized professional development and coaching services, educational instruction services, and technology products that aid in teacher and student evaluations. It also offers tuition payment plans, and service and technology for student billings, payments, and refunds; solutions for in-person, online, and mobile payment experiences on campus; payment processing services, such as credit card and electronic transfer; faith community, giving, and learning management services and technologies; and an integrated commerce payment platform, financial management, and tuition payment plan services, as well as a school management platform that provides administrative, information and financial management, and communication functions for K-12 schools. Its Communications segment provides fiber optic service to homes and businesses for internet, television, and telephone services. The Company's Asset Generation and Management segment acquires, manages, and owns loan assets. Its Nelnet Bank segment operates as an internet industrial bank. The company was founded in 1978 and is headquartered in Lincoln, Nebraska.
Earnings Per Share
As for profitability, Nelnet has a trailing twelve months EPS of $4.24.
PE Ratio
Nelnet has a trailing twelve months price to earnings ratio of 26.65. Meaning, the purchaser of the share is investing $26.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4%.
Moving Average
Nelnet’s value is higher than its 50-day moving average of $109.57 and way above its 200-day moving average of $96.98.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 18.3% and 3425%, respectively.
5. Chart Industries (GTLS)
26.1% sales growth and 5% return on equity
Chart Industries, Inc. manufactures and sells engineered cryogenic equipment for the industrial gas and clean energy markets in the United States and internationally. The company operates in four segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products, and Repair, Service & Leasing. It provides bulk and packaged gas cryogenic solutions for the storage, distribution, vaporization, and application of industrial gases; cryogenic trailers, ISO containers, bulk storage tanks, loading facilities, and regasification equipment for delivering liquefied natural gas (LNG) into virtual pipeline applications; and large vacuum insulated storage tanks as equipment for purchasers of standard liquefaction plants. The company also offers natural gas processing solutions; process technology, liquefaction capabilities, and critical equipment for the LNG, include small to mid-scale facilities, floating LNG applications, and large base-load export facilities; brazed aluminum heat exchangers, Core-in-Kettle heat exchangers, cold boxes, air cooled heat exchangers, pressure vessels, and pipe works; and air cooled heat exchangers and axial cooling fans for the HVAC, power, and refining applications. In addition, it provides highly engineered equipment that is used in specialty end-market applications for hydrogen, LNG, biofuels, CO2 Capture, food and beverage, aerospace, lasers, cannabis, and water treatment; and cryogenic components, include vacuum insulated pipes, specialty liquid nitrogen, end-use equipment, and cryogenic flow meters. Further, it provides extended warranties, plant start-up, parts, 24/7 support, monitoring and process optimization, repairing, maintenance, and upgrading services; plant services on equipment; and service locations that undertake installation, service, repair, maintenance, and refurbishment of cryogenic products, as well as equipment leasing solutions. Chart Industries, Inc. was founded in 1859 and is headquartered in Ball Ground, Georgia.
Earnings Per Share
As for profitability, Chart Industries has a trailing twelve months EPS of $2.24.
PE Ratio
Chart Industries has a trailing twelve months price to earnings ratio of 54.29. Meaning, the purchaser of the share is investing $54.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.6%, now sitting on 3.9B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 115.6% and 64.4%, respectively.
Yearly Top and Bottom Value
Chart Industries’s stock is valued at $121.60 at 01:22 EST, way under its 52-week high of $173.65 and way higher than its 52-week low of $101.60.
6. Radian Group (RDN)
12.5% sales growth and 13.95% return on equity
Radian Group Inc., together with its subsidiaries, engages in the mortgage and real estate services business in the United States. It operates through two segments, Mortgage Insurance and Homegenius segments. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans; and other credit risk management solutions, including contract underwriting. The Homegenius segment offers title services, including a suite of insurance and non-insurance titles; tax and title data, centralized recording, document retrieval, and default curative title services; deed and property reports; closing and settlement services; mortgage underwriting and processing; escrow; appraisal management; and real estate brokerage. This segment also provides real estate valuation products and services; asset management services for managing real estate owned properties, which includes a web-based workflow solution; and a suite of real estate technology products and services to facilitate real estate transactions, such as proprietary platforms as a service solution. It serves mortgage originators, such as mortgage bankers, commercial banks, savings institutions, credit unions, and community banks; and consumers, mortgage lenders, mortgage and real estate investors, government-sponsored enterprises, real estate brokers and agents, and corporations for their employees. The company was formerly known as CMAC Investment Corp. and changed its name to Radian Group Inc. in June 1999. Radian Group Inc. was founded in 1977 and is headquartered in Wayne, Pennsylvania.
Earnings Per Share
As for profitability, Radian Group has a trailing twelve months EPS of $3.84.
PE Ratio
Radian Group has a trailing twelve months price to earnings ratio of 9.15. Meaning, the purchaser of the share is investing $9.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.95%.
Previous days news about Radian Group(RDN)
- According to Zacks on Wednesday, 18 September, "Shares of other insurers like Radian Group (RDN Quick QuoteRDN – Free Report) are trading at a multiple lower than the industry average, while that of Arch Capital Group (ACGL Quick QuoteACGL – Free Report) are trading at a multiple higher than the industry average."
- According to Zacks on Wednesday, 18 September, "Shares of Radian Group (RDN Quick QuoteRDN – Free Report) closed at $35.15 on Tuesday, near its 52-week high of $37.86. "
7. Amphastar Pharmaceuticals (AMPH)
10.5% sales growth and 25.57% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $3.15.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 15.15. Meaning, the purchaser of the share is investing $15.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.57%.
8. Barrett Business Services (BBSI)
6.1% sales growth and 26.18% return on equity
Barrett Business Services, Inc. provides business management solutions for small and mid-sized companies in the United States. The company develops a management platform that integrates a knowledge-based approach from the management consulting industry with tools from the human resource outsourcing industry. It offers professional employer services under which it enters into a client services agreement to establish a co-employment relationship with each client company, assuming responsibility for payroll, payroll taxes, workers' compensation coverage, and other administration functions for the client's existing workforce. The company also provides staffing and recruiting services, such as on-demand or short-term staffing assignment, contract staffing, direct placement, and long-term or indefinite-term on-site management services. It serves electronics manufacturers, light-manufacturing industries, agriculture-based companies, transportation and shipping enterprises, food processors, telecommunications companies, public utilities, general contractors in various construction-related fields, and professional services firms. The company was incorporated in 1965 and is headquartered in Vancouver, Washington.
Earnings Per Share
As for profitability, Barrett Business Services has a trailing twelve months EPS of $1.83.
PE Ratio
Barrett Business Services has a trailing twelve months price to earnings ratio of 20.09. Meaning, the purchaser of the share is investing $20.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.18%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10%, now sitting on 1.1B for the twelve trailing months.
Volume
Today’s last reported volume for Barrett Business Services is 97710 which is 42.91% below its average volume of 171174.
